OOIR: Observatory of International Research

Papers

(The H4-Index of Infection is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Emergence of Campylobacter fetus bacteraemias in the last decade, France	90
Reply to: Differential diagnosis between Kaposi sarcoma-associated herpesvirus cytokine syndrome and hemophagocytic lymphohistiocytosis	69
No link between the prevalence of hepatitis E virus infection and the diagnosis of schizophrenia	62
Risk of hemolysis in Plasmodium vivax malaria patients receiving standard primaquine treatment in a population with high prevalence of G6PD deficiency	59
Diagnosis and management of complicated urogenital schistosomiasis: a systematic review of the literature	54
Horizontal transfer of ΦHKU.vir and its role in the evolution of acapsular emm89 group A Streptococcus in Taiwan	52
Investigation of the pathogen-specific antibody response in periprosthetic joint infection	47
Suspected Buruli ulcer cases in Tonkolili District, Sierra Leone– a prospective cohort study	47
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance: a systematic literature review	44
Preadmission course and management of severe pediatric group A streptococcal infections during the 2022–2023 outbreak: a single-center experience	44
Experience with dalbavancin use in various gram-positive infections within Aberdeen Royal Infirmary OPAT service	43
Immunogenicity and safety of the accelerated 2-dose intradermal rabies pre exposure prophylaxis regimen in immunocompetent and immunocompromised pediatric populations: a comparative study	42
Reply to: Challenges in interpreting the role of gentamicin in treatment of invasive listeriosis: immortal timebias and confounding	41
Rare and risky: a unique case of concurrent chronic pulmonary aspergillosis and lemierre syndrome	37
Outcome of Human Parainfluenza Virus infection in allogeneic stem cell transplantation recipients: possible impact of ribavirin therapy	34
Diagnostic nomogram to differentiate between epididymal tuberculosis and bacterial epididymitis	34
Diagnostic delay in pulmonary blastomycosis: a case series reflecting a referral center experience	32
Live microbials to boost Anti-SARS-CoV-2 immunity clinical trial (Live BASIC trial): a triple-blind randomized controlled trial	31
Household transmission of Omicron variant of SARS-CoV-2 under conditions of hybrid immunity—a prospective study in Germany	31
Efficacy and safety of colistin–doxycycline combination therapy in multi-drug resistance Gram-negative infections: a double-blind randomized controlled trial	31
Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysis	30
Epidemiology and risk factors of community-acquired pneumonia in patients with different causes of immunosuppression	30
Clinical and microbiological characteristics of polymicrobial bacteremia: a retrospective, multicenter study	30
Towards shortening the duration of antibiotic therapy for Lyme borreliosis: a systematic review and meta-analysis	29
Emergence and characterization of mixed Candida auris strain infections in China	29

Blazing the trail for innovative tuberculosis diagnostics	29
Association of stress hyperglycemia ratio and mortality in patients with sepsis: results from 13,199 patients	28
High risk of drug-resistant tuberculosis in IGRA-negative contacts: should preventive treatment be considered?	28